Key Updates in the Management of Patients with Hyperlipidemia

home / peer-exchange / key-updates-in-the-management-of-patients-with-hyperlipidemia

Panelists discuss how recent shifts in treatment patterns and real-world data on low-density lipoprotein cholesterol (LDL-C)–lowering therapies beyond statins can inform clinical decisions and improve outcomes for patients at very high risk post atherosclerotic cardiovascular disease (ASCVD), with an emphasis on the role of pharmacists in enhancing cholesterol management through shared decision-making.

Unmet Needs in the Management of Patients with Hyperlipidemia

EP. 1: Unmet Needs in the Management of Patients with Hyperlipidemia

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP
December 5th 2024

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP, discusses how maximally tolerated statin therapy often fails to achieve target low-density lipoprotein cholesterol levels in high-risk patients with atherosclerotic cardiovascular disease and share strategies for optimizing adherence, including when to switch therapies to improve patient outcomes.

Watch